| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 19, 2003
From the Department of Neurosurgery, University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK (A.K.); Department of Neuroimmunology, University of London, Institute of Neurology and Neurosurgery, London, UK (A.P., G.K., E.T.); Department of Neurosurgery and Center for Nursing Research, University of Pittsburgh, Pittsburgh, Pa (M.K.); and Division of Clinical Neurosciences, University of Southampton, Southampton General Hospital, Southampton, UK (J.N.). * To whom correspondence should be addressed. E-mail: adk4z{at}clinmed.gla.ac.uk.
Background and Purpose--The mechanism underlying the association between possession of the APOE Methods--Enzyme-linked immunosorbent assay was used to assay apoE, A Results--There was a sustained decrease in CSF apoE (P<0.001) and A Conclusions--After SAH both apoE and A
Accepted on July 30, 2003
Temporal Alterations in Cerebrospinal Fluid Amyloid
Andrew Kay MBBS*;
-Protein and Apolipoprotein E After Subarachnoid Hemorrhage
4 allele and less favorable outcome after subarachnoid hemorrhage (SAH) remains to be determined. After SAH the level of apolipoprotein E (apoE) in the cerebrospinal fluid (CSF) is decreased, and lower levels are associated with more severe injury and less favorable outcome. This study examined serial CSF samples to determine the time course for the decrease in CSF apoE and the relationship between CSF apoE and amyloid
-protein (A
), testing the hypothesis that apoE-A
interactions occur in vivo after SAH.
1-40, and A
1-42 in serial ventricular CSF samples from 19 patients with SAH and 13 controls. CSF S100B and
were assayed as surrogate markers of brain injury.
(P<0.001) after SAH in contrast to the observed elevation in CSF S100B (P<0.001) and
(P<0.001) concentration. There was significant correlation between CSF A
concentration and clinical outcome (r=0.65, P<0.01), and the decrease in CSF A
concentration correlated significantly with that of apoE (r=0.85, P<0.0001).
levels decrease in the CSF, supporting the concept that interactions between these proteins occur in vivo. The possibility that apoE and A
influence outcome after SAH warrants further investigation.
This article has been cited by other articles:
![]() |
L. A. Lanterna, Y. Ruigrok, S. Alexander, J. Tang, F. Biroli, L. T. Dunn, and W. S. Poon Meta-analysis of APOE genotype and subarachnoid hemorrhage: Clinical outcome and delayed ischemia Neurology, August 21, 2007; 69(8): 766 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Petzold, G Keir, A Kay, M Kerr, and E J Thompson Axonal damage and outcome in subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Lanterna, M. Rigoldi, G. Tredici, F. Biroli, C. Cesana, S. M. Gaini, and L. Dalpra APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage Neurology, April 12, 2005; 64(7): 1238 - 1244. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |